Thursday, September 4, 2025
12:00pm - 1:00pm
Hybrid Attendance: Research Bldg. 6, 1.206 Auditorium
or
Zoom
https://www.zoomgov.com/s/1609039203?pwd=ZGILbiLGtdLuMnWgX9TrdHhw06tyb2.1
passcode: 089555
Guest Presenter
Maurice Willis, MD, FACP
Division Chief
Professor, Division of Medical Oncology
Professor of Internal Medicine
"The Neutropenic Fever that Bit Me"
Objectives: At this conclusion of this presentation, participants should be able to:
- Be aware of basic Mechanism of Action of some of the newer oncology drugs.
- How to differentiate the newer side effects from other known chemotherapy side effects.
- How to treat these side effects before consult Oncology.
- Knowing why one needs to consult Oncology on every one of these patients.
Target Audience and Needs: Internal Medicine faculty, staff, registered nurses, residents, fellows, students, and internists specializing in Allergy & Immunology, Cardiology, Endocrinology, Gastroenterology, General Medicine,
Geriatrics, Hematology & Oncology, Infectious Diseases, Nephrology, Palliative Care, Pulmonary Critical Care & Sleep Medicine, and Rheumatology need to be regularly updated with new research and guidelines regarding the evaluation
and management of medical disorders and implement them in clinical practice to enhance the quality of patient care and improve patient outcomes.
Educational Methods: Educational methods will include lectures, case presentations, literature review, and panel discussion.
Activity Evaluation: Participants may be asked to complete a session evaluation.
Financial Disclosure: The following are reports of relationships with commercial interests by those individuals who are in the position to control the content of this activity.
Dr. Willis discloses the following commercial interests: Lilly (speaker). Any potential conflicts for this presentation have been resolved, and the speaker attests that the clinical recommendations within this presentation are evidence-based and free of
commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines).
Accreditation/Credit Designation: The University of Texas Medical Branch is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas Medical Branch designates this live activity for a maximum of _1_ AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.